manilatimes28m
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program
NKGen explores the use of troculeucel as a potential treatment option for post-stroke patients. SANTA ANA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) ("NKGen” or the ...
Rolling Out55m
Discover the serious health conditions that triggers stroke
Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...
'I thought my stroke was a headache but within days I couldn't walk or talk'
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Rolling Out23h
5 ways to reduce stroke risk as deaths may rise 50% by 2050
Research predicts stroke deaths may rise 50% globally by 2050, with younger people increasingly affected. Learn effective ...